BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12687601)

  • 1. To the editor: Alcaligenes as a pathogen in airways chronic infection in cystic fibrosis.
    Romano L; Bellodi S; Lugani F; Manno G
    Pediatr Pulmonol; 2003 May; 35(5):412-3. PubMed ID: 12687601
    [No Abstract]   [Full Text] [Related]  

  • 2. Alcaligenes infection in cystic fibrosis.
    Tan K; Conway SP; Brownlee KG; Etherington C; Peckham DG
    Pediatr Pulmonol; 2002 Aug; 34(2):101-4. PubMed ID: 12112775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etiopathogenic and therapeutic aspects of chronic respiratory infection in cystic fibrosis].
    Caramia G; Gagliardini R; Rocchi AL; Palumbo P
    Minerva Pediatr; 1986 Jul; 38(13-14):569-78. PubMed ID: 3528799
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultrastructural abnormalities in young patients with recurrent respiratory infections.
    Robertson B
    Eur J Respir Dis; 1982 Nov; 63(6):496-7. PubMed ID: 6983455
    [No Abstract]   [Full Text] [Related]  

  • 5. [What is the burden of respiratory infection in the progression of cystic fibrosis].
    Bellon G
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S49-55. PubMed ID: 12910134
    [No Abstract]   [Full Text] [Related]  

  • 6. [Respiratory infection in cystic fibrosis: burden of illness in the progression of cystic fibrosis, previous deductions for the microbiological study of bronchial secretions and clinical criteria of infection].
    Thumerelle C
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S37-48. PubMed ID: 12910133
    [No Abstract]   [Full Text] [Related]  

  • 7. [Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].
    Anzaudo MM; Busquets NP; Ronchi S; Mayoral C
    Rev Argent Microbiol; 2005; 37(3):129-34. PubMed ID: 16323660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary infections in cystic fibrosis.
    Acta Paediatr Scand Suppl; 1982; 301():1-132. PubMed ID: 6963850
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rhinosinusal pathology in chronic respiratory diseases in childhood a in mucoviscidosis].
    Romani U; Buffatti G; Mariotti M; Castellarin T
    Minerva Otorinolaringol; 1969; 19(5):237-60. PubMed ID: 5380539
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cystic fibrosis in adolescents].
    Dijkman JH; Kerrebijn KF; Bakker W
    Ned Tijdschr Geneeskd; 1979 Jun; 123(24):1001-4. PubMed ID: 471083
    [No Abstract]   [Full Text] [Related]  

  • 11. [Infection and antibiotic therapy in respiratory manifestations of mucoviscidosis].
    Hennequet A
    Ann Pediatr (Paris); 1968 Mar; 15(3):223-30. PubMed ID: 5744295
    [No Abstract]   [Full Text] [Related]  

  • 12. Some immunologic considerations of chronic pulmonary infection in cystic fibrosis.
    Gifford RR
    J S C Med Assoc; 1972 May; 68(5):204-7. PubMed ID: 4554120
    [No Abstract]   [Full Text] [Related]  

  • 13. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations and treatment of pulmonary infections in cystic fibrosis.
    Burns JL; Ramsey BW; Smith AL
    Adv Pediatr Infect Dis; 1993; 8():53-66. PubMed ID: 8217005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute respiratory infections in patients with cystic fibrosis: role of viruses and mycoplasmas].
    Ojeda-Vargas M; Mateos M; Meseguer M; Baquero F
    Enferm Infecc Microbiol Clin; 1990 Oct; 8(8):526. PubMed ID: 2095268
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic progress--review XVIII. Cystic fibrosis.
    Kohler JA; Rolles CJ
    J Clin Hosp Pharm; 1986 Feb; 11(1):21-32. PubMed ID: 3514681
    [No Abstract]   [Full Text] [Related]  

  • 17. Carbenicillin in pulmonary infection complicating cystic fibrosis.
    Africa E; Rosenblum H
    Del Med J; 1970 Nov; 42(11):307-8. PubMed ID: 5481955
    [No Abstract]   [Full Text] [Related]  

  • 18. Aztreonam: review of the clinical experience and potential uses in pediatrics.
    Lebel MH; McCracken GH
    Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical mycobacterial and fungal infections in cystic fibrosis.
    Whittaker LA; Teneback C
    Semin Respir Crit Care Med; 2009 Oct; 30(5):539-46. PubMed ID: 19760541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.